The ␣-amino-3-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) is an ionotropic receptor mediating excitatory synaptic transmission, but it can also interact with intracellular messengers. Here we report that, at the calyx of Held in the rat auditory brainstem, activation of AMPARs induced inward currents in the nerve terminal and inhibited presynaptic Ca 2؉ currents (IpCa), thereby attenuating glutamatergic synaptic transmission. The AM-PAR-mediated I pCa inhibition was disinhibited by a strong depolarizing pulse and occluded by the nonhydrolyzable GTP analog GTP␥S loaded into the terminal. We conclude that functional AMPARs are expressed at the calyx of Held nerve terminal and that their activation inhibits voltage-gated Ca 2؉ channels by an interaction with heterotrimeric GTP-binding proteins (G proteins). Thus, at a central glutamatergic synapse, presynaptic AMPARs have a metabotropic nature and regulate transmitter release by means of G proteins.
The ␣-amino-3-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) is an ionotropic receptor mediating excitatory synaptic transmission, but it can also interact with intracellular messengers. Here we report that, at the calyx of Held in the rat auditory brainstem, activation of AMPARs induced inward currents in the nerve terminal and inhibited presynaptic Ca 2؉ currents (IpCa), thereby attenuating glutamatergic synaptic transmission. The AM-PAR-mediated I pCa inhibition was disinhibited by a strong depolarizing pulse and occluded by the nonhydrolyzable GTP analog GTP␥S loaded into the terminal. We conclude that functional AMPARs are expressed at the calyx of Held nerve terminal and that their activation inhibits voltage-gated Ca 2؉ channels by an interaction with heterotrimeric GTP-binding proteins (G proteins). Thus, at a central glutamatergic synapse, presynaptic AMPARs have a metabotropic nature and regulate transmitter release by means of G proteins.
calcium channel ͉ excitatory postsynaptic current ͉ synapse ͉ glutamate P ostsynaptic ␣-amino-3-5-methyl-4-isoxazolepropionic acid receptors (AMPARs) mediate glutamatergic synaptic transmission (1, 2) . In addition to their well established ionotropic nature, AMPARs are reported to have a metabotropic nature, interacting with the G protein Gi (3) or the tyrosine kinase Lyn (4) . AMPAR immunoreactivity has been demonstrated at nerve terminals (5, 6) . At the primary sensory nerve terminal, AMPARs regulate transmitter release by means of an ionotropic action (7) , whereas a metabotropic action of AMPARs is proposed to underlie presynaptic inhibition at cerebellar inhibitory synapses (8) .
In the mammalian CNS, nerve terminals at most synapses are too small to make detailed electrophysiological analysis. However, at the calyx of Held visualized in slices of rodent brainstem, whole-cell patch-clamp recordings can be made directly from a giant nerve terminal (9) , and various molecules can be applied into the terminal through patch pipettes (10, 11) . Using this preparation, we demonstrate here that functional AMPARs are expressed in the calyceal nerve terminal and inhibit voltagegated Ca 2ϩ currents through a coupling with heterotrimeric G proteins.
Methods Preparations and Solutions.
All experiments were performed in accordance with the guidelines of the Physiological Society of Japan. Wistar rats (7-8 days old) were decapitated under halothane anesthesia, and the brain was quickly removed. Transverse brainstem slices (175-250 m in thickness) containing the medial nucleus of the trapezoid body (MNTB) were cut by using a tissue slicer (ZERO-1, Dosaka, Kyoto, Japan) as described in ref. 12 . Slices were incubated at 37°C for 30 min and subsequently maintained at room temperature in artificial cerebrospinal fluid (aCSF) containing 125 mM NaCl, 2.5 mM KCl, 26 mM NaHCO 3 , 1.25 mM NaH 2 PO 4 , 2 mM CaCl 2 , 1 mM MgCl 2 , 10 mM glucose, 3 mM myo-inositol, 2 mM sodium pyruvate, and 0.5 mM ascorbic acid, pH 7.4, when bubbled with 95% O 2 and 5% CO 2 . MNTB neurons and calyces were visualized with a ϫ60 water immersion objective lens (Olympus, Tokyo) attached to an upright microscope (Axioskop, Zeiss). For recording excitatory postsynaptic currents (EPSCs), the aCSF routinely contained bicuculline methiodide (10 M, Sigma) and strychnine hydrochloride (0.5 M, Sigma) to block inhibitory synaptic responses. The patch pipette solution for postsynaptic recording contained 110 mM CsF, 30 mM CsCl, 10 mM Hepes, 5 mM EGTA, and 1 mM MgCl 2 (295-305 milliosmolar, pH 7.3, adjusted with CsOH). N-(2,6-diethylphenylcarbamoylmethyl)-triethyl-ammonium chloride (QX314, 5 mM, Alomone Labs, Jerusalem) was also included in the pipette solution to block action potential generation. The pipette solution for recording calcium currents from calyceal terminals contained 110 mM CsCl, 10 mM tetraethylammonium chloride (TEACl), 40 mM Hepes, 0.5 mM EGTA, 1 mM MgCl 2 , 12 mM Na 2 phosphocreatine, 2 mM ATP-Mg, and 0.5 mM GTP-Na (295-305 milliosmolar, pH 7.3 adjusted with CsOH). The pipette solution for recording presynaptic barium currents (I pBa ) contained 95 mM CsCl, 10 mM TEACl, 40 mM Hepes, 10 mM EGTA, 6 mM CaCl 2 , 1 mM MgCl 2 , 12 mM Na 2 phosphocreatine, 2 mM ATP-Mg, and 0.5 mM GTP-Na (295-305 milliosmolar, pH 7.3 adjusted with CsOH). The pipette solution for recording presynaptic potassium currents (I pK ) and currentclamp recording contained 97.5 mM potassium gluconate, 32.5 mM KCl, 10 mM Hepes, 5 mM EGTA, 1 mM MgCl 2 , 12 mM Na 2 phosphocreatine, 2 mM ATP-Mg, and 0.5 mM GTP-Na (295-305 milliosmolar, pH 7.3, adjusted with KOH). Tetrodotoxin (1 M) (Wako Pure Chemical, Osaka, Japan) was added to aCSF in the presynaptic recordings, and TEACl (10 mM, equimolar replacement of NaCl) was also added for recording calcium or barium currents.
Recording and Analysis. Whole-cell patch-clamp recordings were made from MNTB principal neurons or presynaptic calyceal nerve terminals. EPSCs were evoked every 20 s by extracellular stimulation of presynaptic axons using a bipolar tungsten electrode positioned halfway between the midline and the MNTB. For recording presynaptic Ca 2ϩ currents (I pCa ), I pBa , and I pK , calyces were voltageclamped at a holding potential of Ϫ80 mV, and depolarizing voltage steps were applied every 10-20 s. The current amplitude was measured 2-3 ms after the onset of the depolarizing pulse. The electrode resistance was 2-4 M⍀ for postsynaptic recordings and 5-8 M⍀ for presynaptic recordings. The access resistance of postsynaptic recordings was 7-21 M⍀ and was not compensated for. The presynaptic access resistance was 7-20 M⍀ and was compensated by up to 80%. Leak currents in whole-cell recordings This paper was submitted directly (Track II) to the PNAS office.
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were subtracted by the scaled pulse (P͞8) protocol. Current and voltage recordings were made by using a patch-clamp amplifier (Axopatch-1D or Axopatch-200B, Axon Instruments, Union City, CA). Records were low-pass-filtered at 5 kHz and digitized at 20-50 kHz by an analog-digital converter (Digidata 1322A) with PCLAMP8 software (both from Axon Instruments). The liquid-junction potentials between the pipette solutions and aCSF were ϩ2 mV for I pCa and I pBa recordings and ϩ10 mV for I pK recordings, which were not corrected for. Drugs were bath-applied by switching superfusates, using solenoid valves (perfusion rate ϭ 1.5-2.0 ml͞min). Experiments were carried out at room temperature (22-25°C) . Values in the text and figures are given as mean Ϯ SEM, and statistical comparisons were made by using Student's paired t test, unless otherwise noted.
, and (2S,4R)-4-methylglutamic acid (SYM2081) were purchased from Tocris Cookson (Bristol, U.K.).
Results
An AMPA͞Kainate Receptor Agonist Inhibited NMDA-EPSCs. Bath application of the AMPA͞kainate receptor agonist domoate (10 M) inhibited EPSCs recorded at a holding potential of ϩ40 mV at the calyx of Held (Fig. 1A) . To assess the site of its action, before domoate application, we separated the NMDA receptor and AMPAR components by blocking the former with D-AP5 (50 M) ( Fig. 1 A, traces a Ϫ b and c Ϫ d). This treatment revealed that AMPA component returns to the baseline at the peak of NMDA-EPSCs (arrow in trace a). The magnitude of domoate-induced inhibition of NMDA-EPSCs, estimated by subtraction ( Fig. 1 A, trace a Ϫ b vs. trace c Ϫ d), was 71.8 Ϯ 2.9%, whereas that of AMPA-EPSCs estimated in the presence of D-AP5 ( Fig. 1 A, trace b vs. trace d) was 93.0 Ϯ 1.0% (n ϭ 4). Thus, domoate inhibited both AMPA-and NMDA-EPSCs, suggesting that the main site of its action is presynaptic. To confirm the presynaptic site of domoate action, we compared the paired-pulse ratios (PPRs) of EPSCs (interstimulus interval ϭ 20 ms) before and during domoate applications. As shown in Fig.  1B , domoate increased PPRs by 102 Ϯ 38% (n ϭ 7; P Ͻ 0.05), confirming that the main site of domoate action is presynaptic. Greater inhibition of AMPA-EPSCs compared with NMDAEPSCs ( Fig. 1 A) suggests that domoate might additionally affect postsynaptic AMPARs.
Presence of Functional AMPARs at the Calyceal Nerve Terminal. The presynaptic inhibitory effect of domoate on EPSCs implies that functional AMPA͞kainate receptors might be expressed in the nerve terminal. We investigated this possibility by making wholecell recordings directly from calyceal nerve terminals. Bath application of domoate (10 M) depolarized the terminal by 8.6 Ϯ 0.5 mV (n ϭ 5) in current-clamp mode and induced an inward current of 117 Ϯ 20 pA (n ϭ 6) under voltage-clamp at a holding potential of Ϫ80 mV ( Fig. 2A) . AMPA (10 M) also depolarized the terminal by 1.7 Ϯ 0.5 mV (n ϭ 5; P Ͻ 0.05) and induced an inward current of 23.5 Ϯ 4.6 pA (n ϭ 5; Fig. 2B ). In the presence of CTZ (100 M), which blocks AMPAR desensitization, AMPA (10 M) depolarized the terminal by 7.6 Ϯ 0.6 mV and induced inward currents of 69.2 Ϯ 18.9 pA (n ϭ 5; Fig. 2C ). AMPA͞kainate receptor antagonist CNQX (20 M) abolished these effects (n ϭ 4; Fig. 2D ). These results indicate that the calyx of Held terminal expresses functional AMPARs, which are more strongly desensitized by AMPA than by domoate, as previously reported in somatic glutamate receptors (GluRs) (13) .
AMPA Receptor Agonists Inhibit Presynaptic Ca 2؉ Currents but Do Not
Affect K ؉ Currents. At the calyx of Held, presynaptic depolarization up to 10 mV moderately potentiates EPSCs (14, 15) . Therefore, the presynaptic inhibitory effect of domoate ( Fig. 1 ) cannot be explained by the direct depolarizing effect of AMPAR agonists on the terminal (Fig. 2) . Thus, we examined the possibility that AMPAR agonists might affect I pCa by means of a metabotropic pathway. As illustrated in Fig. 3A1, bath Fig. 3A2) (Fig.  3A3) , confirming that it is mediated by AMPARs. Bath application of AMPA (10 M) alone slightly attenuated I pCa (2.4 Ϯ 0.3%; n ϭ 5; data not shown), and in the presence of CTZ (100 M), it attenuated I pCa by 18.9 Ϯ 3.6% (at 0 mV, n ϭ 5; P Ͻ 0.01; Fig. 3B ). Bath application of the endogenous ligand L-glutamate (100 M) inhibited I pCa by 33.7 Ϯ 1.3% (n ϭ 4) in the absence of CTZ but in the presence of the metabotropic glutamate receptor (mGluR) antagonists CPPG (300 M) and (R,S)-␣-methyl-4-carboxyphenylglycine (500 M) (Fig. 3C) . CNQX (20 M) attenuated this inhibitory effect of L-glutamate by 48% (I pCa inhibition with CNQX ϭ 16.1 Ϯ 2.5%; n ϭ 4), suggesting that L-glutamate activated presynaptic AMPARs, thereby inhibiting I pCa . The CNQX-resistant I pCa inhibition by L-glutamate might arise from mGluRs resistant to the antagonists used.
We next investigated whether AMPAR agonists might affect I pK (17) . As shown in Fig. 3D , domoate (10 M) had no effect on I pK at all voltages examined. Similarly, AMPA with CTZ had no effect on I pK (n ϭ 5; see Fig. 6 , which is published as supporting information on the PNAS web site). . (D) Domoate (10 M) had no effect on IpK evoked by a 50-ms depolarizing pulse stepping to various potentials (averaged IpK at each potential are superimposed in traces). In the current-voltage relationships, the mean amplitude of I pK was normalized to control at 0 mV. Open and filled circles represent data points before and during application of domoate (n ϭ 5).
4A). Intraterminal loading of the GDP analogue GDP␤S (3 mM) also significantly attenuated the AMPA-induced I pCa inhibition (from 18.9 Ϯ 3.6% to 9.6 Ϯ 1.0%; n ϭ 5; P Ͻ 0.02, unpaired t test). These results indicate that G proteins are involved in the presynaptic inhibitory effect of AMPAR agonists on I pCa .
Inhibition of calcium currents mediated by the G protein ␤␥-subunit (G␤␥) can be removed by a strong depolarizing prepulse, which transforms the voltage gates of Ca 2ϩ channels from a reluctant state to a willing state (19) (20) (21) . We examined whether this voltage-dependent unblock might be observed for the AMPA-induced I pCa inhibition. As shown in Fig. 4B , a conditioning prepulse (from Ϫ80 mV to ϩ100 mV for 10 ms) significantly disinhibited I pCa evoked by the test pulses (5 ms to different membrane potentials; P Ͻ 0.05 at Ϫ20, Ϫ10, and 0 mV; n ϭ 5), suggesting that the AMPA-induced I pCa inhibition may be mediated by G␤␥.
Direct Inhibitory Effect of AMPA on IpCa. Our present results suggest that AMPAR agonists directly activate presynaptic AMPARs and inhibit I pCa by means of G proteins. However, it might be argued that the inhibitory effect of AMPAR agonists arose secondarily from their actions on AMPARs in surrounding cells in slices. Given that tetrodotoxin is present in the aCSF, depolarization of somata by AMPAR activation is unlikely to depolarize nerve terminals. However, local depolarization of nerve terminals or somata by means of AMPAR activation might release transmitters and͞or neuromodulators such as GABA, glutamate, adenosine, and noradrenaline, thereby indirectly activating G protein-coupled receptors (GPCRs) in the calyceal presynaptic terminal (22) (23) (24) (25) . To examine this possibility, we first tested the effect of AMPA (with CTZ) on I pCa in the presence of GPCR antagonists, including the GABA B receptor antagonist 3-aminopropyl(diethoxymethyl)phosphinic acid (CGP35348) (100 M), the group II͞III mGluR antagonist CPPG (300 M), the adrenaline ␣ 2 receptor antagonist yohimbine (20 M) , and the adenosine A 1 receptor antagonist 8-cyclopentyl-1,3-dimethylxanthine (10 M) (Fig. 5A) . We also added the kainate receptor-desensitizing antagonist (2S,4R)-4-methylglutamic acid (SYM2081) (3 M) to examine whether kainite receptors are involved. In this solution, AMPA (10 M with CTZ) inhibited I pCa by 23.7 Ϯ 2.6% (n ϭ 5 at 0 mV; Fig. 5A ), which was similar to the inhibition without the antagonists (P ϭ 0.32, unpaired t test). Thus, these results pharmacologically rule out the involvement of GABA B receptors, mGluRs, ␣ 2 receptors, A 1 receptors, and kainate receptors in the AMPA-induced I pCa inhibition. However, these results do not entirely rule out the possible involvement of as yet unidentified messengers, which might be released in response to AMPAR agonists. To examine this possibility, we made two types of experiments. First, we destroyed postsynaptic MNTB cells by gentle blows and suctions of cell membrane through a largish patch pipette (orifice diameter Ϸ 3-5 m). After destroying the postsynaptic cells, calyceal terminals were practically isolated from surrounding cells (Fig.  5B) . Bath application of AMPA (10 M plus 100 M CTZ) to these calyces clearly inhibited I pCa by 18.9 Ϯ 3.0% (at 0 mV, n ϭ 5), which is similar in magnitude to control. Second, we blocked depolarization-induced exocytosis by replacing Ca 2ϩ in the aCSF with Ba 2ϩ , which nearly abolished synaptic transmission at the calyx of Held (Fig. 7A , which is published as supporting information on the PNAS web site) as previously reported at the squid giant synapse (26) and also markedly attenuated the potassiuminduced increase in the miniature EPSC frequency (Fig. 7B) . Furthermore, to exclude possible involvements of retrograde messengers, we included 4-methyl-1H-pyrazole-3-carboxamide (AM251) (5 M), N-nitro-L-arginine (1 mM), and 2,4Јdibro-moacetophenone (10 M) in the aCSF to block cannabinoid CB1 receptors (27) , NO synthetase, and phospholipase A 2 , respectively. Even in this condition, AMPA (10 M plus CTZ) inhibited I pBa by 18.8 Ϯ 2.9% (n ϭ 5; Fig. 5C ) to a similar extent as it inhibited I pCa (Fig. 3B) . Furthermore, GTP␥S (0.2 mM) loaded into the calyceal terminals abolished the inhibitory effect of AMPA on I pBa (0.8 Ϯ 0.7%; n ϭ 5). Taken together, these results strongly suggest that direct activation of functional AMPARs in the calyceal terminal inhibits presynaptic Ca 2ϩ currents by means of G proteins.
Discussion
By taking advantage of the large calyx of Held nerve terminal, we have demonstrated that activation of presynaptic AMPARs inhibits voltage-gated Ca 2ϩ channels by means of G proteins, most likely through G␤␥, thereby inhibiting transmitter release from the nerve terminal. Presynaptic AMPARs also showed an ionotropic nature, depolarizing the nerve terminal by 5-10 mV upon activation by ligands. Although presynaptic depolarization of this magnitude increases transmitter release (14, 15) , this facilitatory effect seems to be masked by the stronger inhibitory effect mediated by G proteins.
Biochemical studies first demonstrated that activation of AMPARs inhibits adenylyl cyclase by means of Gi (3). Subsequently, in retinal ganglion cells, activation of AMPARs was shown to inhibit cGMP-gated currents in a G protein-dependent manner (18) . More recently, at a cerebellar inhibitory synapse, the G protein inhibitor N-ethylmaleimide is reported to attenuate the AMPAR-mediated presynaptic inhibition (8) . Our present results are in line with these reports and demonstrate more directly that AMPARs are coupled with heterotrimeric G proteins in the nerve terminal and that their activation leads to inhibition of voltage-gated Ca 2ϩ channels. The detailed molecular mechanism by which AMPARs couple with G proteins remains to be determined.
Ionotropic GluRs comprise three categories: AMPARs, NMDA receptors (NMDARs), and kainate receptors (1, 2) , all of which are expressed in nerve terminals, in addition to postsynaptic neurons. NMDARs are expressed in cerebellar nerve terminals (29) and are involved in the long-term depression of excitatory transmission (30) or the retrograde enhancement of transmitter release (31) . NMDARs are also expressed at the primary afferent terminals in the spinal cord (32) and are thought to regulate action potential invasion (33) . However, it is not known whether presynaptic NMDARs are linked with G proteins. Kainate receptors expressed in hippocampal nerve terminals modulate transmitter release (34) (35) (36) bidirectionally, depending on the concentration of the agonist (37) . Kainate receptors expressed in dorsal root ganglion cells are coupled with G proteins and inhibit Ca 2ϩ channels upon activation with agonists (38) . In the hippocampus, both at the inhibitory (39, 40) and excitatory (41) synapses, presynaptic kainate receptors are proposed to couple with G proteins for inhibiting transmitter release. Although we did not observe kainate receptor-dependent presynaptic inhibition at the calyx of Held terminal, a common intracellular mechanism might underlie the presynaptic inhibition by kainate receptors and AMPA receptors.
It has been reported that the glutamate receptor (GluR) subunits of AMPARs are expressed at various nerve terminals. Axonal growth cones of hippocampal neurons are immunopositive to GluR1 and GluR2 (42) . Similarly, GluR1-4 immunoreactivities are observed at the nerve terminal of developing rat striatum (5) and at the primary afferent terminals (6) . GluR4 immunogold particles are observed in presynaptic structures at the hair cell ribbon synapse (43) and at the end bulb of Held synapse in the anteroventral cochlear nucleus of auditory brainstem (44) . At cerebellar inhibitory synapses (8, 45) and spinal cord excitatory synapses (7), presynapticAMPARsinhibittransmitterrelease.Thus,theAMPARmediated presynaptic inhibition may be widespread among central synapses.
At the excitatory synapse, glutamate released from nerve terminals can inhibit transmitter release by means of activating mGluRs and AMPA͞kainate receptors in the nerve terminal, both of which inhibit presynaptic Ca 2ϩ entry by means of G protein activation. In this respect, metabotropic and ionotropic glutamate autoreceptors may cooperate for saving transmitters from depletion and protecting neurons from glutamate excitotoxicity in the pathological conditions. Although bath application of L-glutamate inhibited presynaptic Ca 2ϩ currents by means of AMPAR activation, we could not detect inhibition of presynaptic Ca 2ϩ currents by glutamate released by repetitive presynaptic stimulation Hz; n ϭ 5; data not shown). However, this result does not preclude physiological or pathological roles of presynaptic AMPARs at the calyx of Held in vivo. More importantly, our results suggest that presynaptic AMPARs at various central synapses may play a regulatory role for transmitter release by means of heterotrimeric G proteins.
We thank Mark Farrant, Shiro Konishi, and Tetsuhiro Tsujimoto for comments on the manuscript and Ken Kitamura for advice. This work was supported by a Grant-in-Aid for Specially Promoted Research from the Ministry of Education, Culture, Sports, Science, and Technology. Fig. 7 ). The aCSF contained the retrograde messenger blockers 4-methyl-1H-pyrazole-3-carboxamide (AM251) (5 M), N-nitro-L-arginine (1 mM), and 2,4Јdibromoacetophe-none (10 M). Intraterminal free Ca 2ϩ concentration was set at 90 nM with a Ca 2ϩ buffer (6 mM CaCl2͞10 mM EGTA) included in the patch pipette to preserve the G protein-mediated inhibition of Ba 2ϩ currents (28) . In the absence of Ca 2ϩ in the pipette solution, the IpBa inhibition by AMPA (10 M) was smaller (6.0 Ϯ 1.7%; n ϭ 5; data not shown). When GTP␥S (0.2 mM) was included in the pipette solution (together with 90 nM Ca 2ϩ buffer), AMPA (10 M) no longer inhibited Ba 2ϩ currents (filled circles). Data are derived from five terminals each for control and GTP␥S loading. Sample records are IpBa in the presence (traces e and f, superimposed) and absence (traces g and h, superimposed) of GTP␥S before (e and g) and during (f and h) application of AMPA (10 M).
